Poseida Therapeutics, Inc. (51) | License Agreements (10)

Recent Contracts

Amended and Restated License Agreement, by and between the Registrant and Helmholtz-Zentrum MnchenDeutsches Forschungszentrum fr Gesundheit und Umwelt GmbH, executed as of March... (Filed With SEC on May 11, 2021)
License Agreement, by and between the Registrant and Janssen Biotech, Inc., effective August 3, 2015 (Filed With SEC on June 19, 2020)
Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective April 27, 2017 (Filed With SEC on June 19, 2020)
Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective August 3, 2018 (Filed With SEC on June 19, 2020)
License Agreement, by and between the Registrant and Helmholtz-Zentrum MnchenDeutsches Forschungszentrum fr Gesundheit und Umwelt GmbH, effective May 20, 2016 (Filed With SEC on June 19, 2020)
License Agreement, by and between the Registrant and Genus Oncology, LLC, effective October 24, 2019 (Filed With SEC on June 19, 2020)
License Agreement, by and between the Registrant and Janssen Biotech, Inc., effective August 3, 2015 (Filed With SEC on January 4, 2019)
Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective April 27, 2017 (Filed With SEC on January 4, 2019)
Commercial License Agreement, by and between the Registrant and TeneoBio, Inc., effective August 3, 2018 (Filed With SEC on January 4, 2019)
License Agreement, by and between the Registrant and Helmholtz-Zentrum MnchenDeutsches Forschungszentrum fr Gesundheit und Umwelt GmbH, effective May 20, 2016 (Filed With SEC on January 4, 2019)